Clinical Updates

Adding more weight to concerns about possible long-term dangers of osteoporosis drugs, a new study finds that people who… »   

Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest… »   

Adding Johnson & Johnson’s advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first… »   

A U.S. Food and Drug Administration advisory panel recommended Tuesday approval of the first HIV test that would give people… »   

The Food and Drug Administration is questioning the benefits and risks of a new rheumatoid arthritis drug created by Pfizer,… »   

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug… »   

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that typically affects the hands and feet, although any joint lined… »   

Officials of India’s drug regulator have been colluding with pharmaceutical firms to speed up approval procedures, allowing some drugs that… »   

GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its… »   

Diamond Pet Foods has expanded a recall of its dry dog food, taking precautionary steps after several of its brands… »   

Pfizer Inc’s experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive… »   

The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according… »   

In an analysis of over 40,000 clinical trials registered in a government database, researchers found that many of those studies… »   

Pfizer Inc, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt… »   

The U.S. Food and Drug Administration should review drugs on a regular basis for as long as they are on… »